Skip to main content
. 2017 Mar 17;45(8):4344–4358. doi: 10.1093/nar/gkx159

Figure 1.

Figure 1.

In vitro EC differentiation system from ES cells. (A) Schematic view of the strategy to comprehensive data analysis with dynamic EC differentiation. (B) Flow cytometry data representation. X and Y-axis indicate Pecam1 and VE-cadherin positive cell counts, respectively. The rate of both Pecam1 and VE-cadherin positive ECs derived from total Flk-1 cell-derived cells were indicated into the panel (%). Cells were treated in the absence (left) or presence (right panel) of 50 ng/ml VEGF. (C) Immuno-staining data with antibodies to Pecam1 (green, left) and α-SMA (red, middle panel). Merged images were shown in right. Cells were treated with (upper) or without 50 ng/ml VEGF (lower panel). Scale bar: 50 μm.